
Maria Heeter
@heetermaria
U.S. Deals @FT.
Here for you but I work for tips: Call/text me 6033197139 (on WhatsApp, Signal, etc). @TheInformation alum.
ID: 1095519389728747520
13-02-2019 03:05:51
2,2K Tweet
4,4K Followers
3,3K Following


#Pharma deals fall to lowest level in almost a decade ft.com/content/54a1d8… #FT story by Maria Heeter + Oliver Barnes + Ian Johnston Back in June #Bloomberg were reporting that sector transaction values were cooling, with private deals leading M&A bloomberg.com/news/articles/…


Blackrock has swung a heavy bat this year as Larry Fink's ambition in private capital has come into full view. Nearly $20bn of BLK's M&A uses its stock, underscoring the importance of a valid acquisition currency + cash. Eric Platt Brooke Masters ft.com/content/70a053…

Just another Merger Monday... ft.com/content/01eb51… Maria Heeter James Fontanella-Khan Antoine Gara


Blue Owl co-founder seeking multiway merger to form PE investment giant Billionaire dealmaker Michael Rees sounds out potential partners to assemble new firm in mould of Blackstone via Maria Heeter Antoine Gara Financial Times #PrivateEquity on.ft.com/3ZJ0COv

Over-paid, over-sized and over here. American asset managers are elbowing aside European ones on their home turf. Good piece on another facet of US exceptionalism by Harriet Agnew and Brooke Masters ft.com/content/bc1b6e…

Michael Rees, the pioneer of staking powerful private capital groups, has been sounding out dealmakers on the idea of a 3-to-5 firm merger among companies in his portfolio. A complex deal concept in a fast consolidating industry. From Maria Heeter & me ft.com/content/33193d…


Some of the best tech reporting of the year Ashlee Vance Cory Weinberg Kate Clark Maria Heeter Deepa Seetharaman keachhagey Berber Jin Kate Linebaugh rat king 🐀 erin griffith Kylie Robison







The new year is a good chance for IPO bankers to start getting excited about 2026 George Hammond



🚨💉JPM DEAL SCOOP💉🚨 Eli Lilly, the world's biggest drugmaker by market value, is in advanced talks to buy targeted therapy cancer biotech Scorpion Therapeutics in a deal worth up $2.5bn With superstar deals team Maria Heeter & James Fontanella-Khan ft.com/content/fdd081…

.Financial Times scoop from Hannah Kuchler & me confirmed: GSK to buy cancer biotech IDRx for $1bn and $150mn earnout


.Financial Times scoop on Eli Lilly buying Scorpion confirmed!